Filing Details
- Accession Number:
- 0001079973-24-000893
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-17 15:13:41
- Reporting Period:
- 2024-06-13
- Accepted Time:
- 2024-06-17 15:13:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516077 | Edward Clarence Smith | 1409 Peachtree Road Daytona Beach FL 32114 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-13 | 3,400,000 | $0.01 | 65,114,444 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-06-14 | 3,100,000 | $0.01 | 68,214,444 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,572,649 | Indirect | See Footnote |
| Common Stock | 1,850,000 | Indirect | See Footnote |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | $0.03 | 2028-12-06 | 27,600,000 | 27,600,000 | Direct | |
| Common Stock | Stock Option | $0.03 | 2028-12-06 | 4,750,000 | 4,750,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2028-12-06 | 27,600,000 | 27,600,000 | Direct |
| 2028-12-06 | 4,750,000 | 4,750,000 | Direct |
Footnotes
- Shares purchased in private placement of the Company.
- Shares held by the Clarence E. Smith Trusts.
- Shares held by Mr. Smith's retirement account.
- Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan.
Billionaire Hedge Funds
